Resource utilization and cost saving analysis of subcutaneous versus intravenous trastuzumab in early breast cancer patients

We conducted an economic evaluation of intravenous (IV) vs subcutaneous (SC) trastuzumab for the treatment of patients with early breast cancer (EBC). Data of patients receiving adjuvant IV trastuzumab at our institute in 2014 were used to study three different treatment scenarios: 1) IV trastuzumab...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Farolfi, Alberto, Silimbani, Paolo, Gallegati, Davide, Petracci, Elisabetta, Schirone, Alessio, Altini, Mattia, Masini, Carla
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Clinical Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5655288/
https://ncbi.nlm.nih.gov/pubmed/29113393
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.18527
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados